23.5 C
New York
Thursday, July 3, 2025

Tag: science

newssourcecompanyFORcontentinformation1marketbusiness

Nixol Weight Loss Capsules UK & IE Officially Launched- Exploring the Science Behind its Weight Loss Tablets Promises

New York City, NY, July 03, 2025 (GLOBE NEWSWIRE) -- In 2025, Nixol, a plant-based dietary supplement, made its debut in the United Kingdom and Ireland, marking a significant entry into the wellness supplement market. Designed to support healthy weight management, boost metabolism, and curb cravings, Nixol has positioned itself as a natural, vegan-friendly alternative to traditional weight loss solutions. Unlike products that rely on synthetic stimulants or restrictive diets, Nixol leverages a blend of carefully selected, science-backed ingredients to promote sustainable fat reduction and overall well-being. This article provides an in-depth exploration of Nixol’s launch, its formulation, claims, scientific backing, customer feedback, and the broader context of its market entry, while critically examining its potential effectiveness and limitations. Visit Official Website 

Bond, debond, recycle – tesa opens new Debonding on Demand laboratory in Singapore

Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...

HYDROFUEL’s University of Toronto Team wins Royal Society of Chemistry Environment, Sustainability and Energy Prize for its Optochemical Research

TORONTO, July 3, 2025 /CNW/ - Hydrofuel Canada Inc. ("Hydrofuel") is pleased to announce that its University of Toronto ("UofT") Solar Fuels Cluster Research Team...

Elon Snags Air Permit — Protests Be Damned

Elon Musk’s xAI data center in Memphis just got the nod from the local health department to keep its gas turbines running, despite a...

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20insApproval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which...

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

The sleep apnea market growth is driven by rising awareness, technological advancements, and demand for personalized care. Companies innovate therapies and solutions for better...

LEATT HONORED TWICE AT EUROBIKE 2025

5.0 Gravity Helmet Wins Eurobike Gold Award for Technical Highlight; 6.0 HydraDri Jacket Wins Eurobike Winner Award for Performance Clothing at World's Leading Cycling...

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025

LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.

Sesh Fitness App Launches Free Strength Training & Nutrition Plan to Eliminate Biggest Barriers for Women Starting Their Fitness Journey

LOUISVILLE, Ky., July 2, 2025 /PRNewswire/ -- Sesh, the female-founded fitness app transforming how women build strength, is removing one of the biggest obstacles to...

AxonDAO Awards Strategic Grant to Ranger to Advance Decentralized Visual Data Collection

Cheyenne, Wyoming, USA, July 02, 2025 (GLOBE NEWSWIRE) -- AxonDAO, a decentralized science (DeSci) organization building open-source infrastructure for ethical AI and scientific discovery, has awarded a strategic grant to Ranger, a platform that pays users to upload photos used in real-world research. The collaboration supports AxonDAO’s mission to empower individuals to contribute to science while retaining ownership and value from their data.

Arthro MD+ Joint Relief Cream Officially Launches: Natural Fast-Acting Solution in US, CA, UK, AU, NZ and IE

Arthro MD Cream launches in the US, Canada, UK, Australia, and Ireland, offering a science-backed, natural solution for joint pain and mobility. Fast-acting, non-greasy formula for seniors, athletes, and more. 
Arthro MD Cream launches in the US, Canada, UK, Australia, and Ireland, offering a science-backed, natural solution for joint pain and mobility. Fast-acting, non-greasy formula for seniors, athletes, and more.

TRREB Supports Post-Secondary Students With Eight Scholarship Awards

TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Eight students joined the Toronto Regional Real Estate Board’s (TRREB) and its Member REALTORS® growing list of Past President’s scholarship winners. The winners are all high school students pursuing post-secondary education. Each student was required to write a compelling essay focused on one of two key issues – transportation gridlock or changing weather conditions for a chance at a $5,000 first-place award, a $2,500 second-place award, third-place award for $2,000 and fourth-place for a $1,500 award.

OXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients

OXLUMO has been shown to significantly reduce urinary oxalate, which drives the progression of PH1 Disease1 MISSISSAUGA, ON, July 2, 2025 /CNW/ - Alnylam Canada ULC...

Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma

Lynozyfic is a bispecific antibody directing T cells to kill multiple myeloma cancer cells; multiple myeloma is the second most common blood cancer 

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsScience

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers